Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

http://www.businessweek.com/ap/2012-10-03/antares-pharma-aims-to-raise-47m-from-stock-sale

AP News

Antares Pharma aims to raise $47M from stock sale


EWING, N.J. (AP) — Antares Pharma Inc. said Wednesday that it plans to sell 12.5 million shares of its stock for $4 per share, raising about $47 million after expenses.

Antares makes self-injectable drugs. The company said Tuesday that it was planning to sell more stock to fund development of Vibex Medi-Jet, a delivery system for the rheumatoid arthritis drug methotrexate, and Vibex QST, which is designed to deliver testosterone as a treatment for low testosterone levels. The underwriters of the sale will have the option to buy another 1.9 million shares to cover any overallotments.

The offering is priced at a 9 percent discount to Tuesday's closing price of $4.40. Shares of Antares fell 37 cents, or 8.4 percent, to $4.03 in afternoon trading Wednesday.

It has traded between $1.51 and $5.58 in the last 12 months.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus